Literature DB >> 3260925

Accessory cells, dendritic cells, or monocytes, are required for the lymphokine-activated killer cell induction from resting T cell but not from natural killer cell precursors.

O Silvennoinen1, J Vakkila, M Hurme.   

Abstract

In this study we have investigated the role of accessory cells in the development of lymphokine-activated killer cells (LAK) from highly purified human NK and small resting T cell progenitors. As accessory cells we used autologous, as well as allogeneic, monocytes, and dendritic cell enriched cells. Both NK and T cells were able to generate LAK activity, but their activation requirements were different. NK cells were activated merely by IL-2, and accessory cells did not enhance their lytic activity in the presence or absence of IL-2. Conversely, T cells were practically unresponsive to even high concentrations of IL-2 having a strict requirement for accessory cells for the development of lytic activity and proliferation. Accessory cells differed in their ability to activate T cells presumably depending on their ability to induce IL-2 synthesis, allogeneic dendritic cells being the most effective accessory cells and IL-2 synthesis stimulators. Allogeneic accessory cells could induce lytic activity in T cells even in the absence of exogenous IL-2. Thus, accessory cells play a central role in expanding the LAK effector cell population.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3260925

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

1.  Human lymphokine-activated killer (LAK) cells. I. Depletion of monocytes from peripheral blood mononuclear cells by L-phenylalanine methyl ester: an optimization of LAK cell generation at high cell density.

Authors:  K H Leung
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

2.  Melanoma-specific cytotoxic T cells generated from peripheral blood lymphocytes. Implications of a renewable source of precursors for adoptive cellular immunotherapy.

Authors:  C L Slingluff; T L Darrow; H F Seigler
Journal:  Ann Surg       Date:  1989-08       Impact factor: 12.969

3.  Indirect inhibition of generation of murine lymphokine-activated killer cell activity in splenocyte cultures by interferon-gamma.

Authors:  T Y Chao; H Ohnishi; T M Chu
Journal:  Immunology       Date:  1990-05       Impact factor: 7.397

4.  Bacterial superantigens as anti-tumour agents: induction of tumour cytotoxicity in human lymphocytes by staphylococcal enterotoxin A.

Authors:  P A Lando; G Hedlund; M Dohlsten; T Kalland
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

5.  Evidence that interleukin-4 suppression of lymphokine-activated killer cell induction is mediated through monocytes.

Authors:  B Brooks; H Parry; J Lawry; R Rees
Journal:  Immunology       Date:  1992-02       Impact factor: 7.397

6.  Phenotypic and functional analysis of lymphokine-activated killer (LAK) cell clones. Ability of CD3+, LAK cell clones to produce interferon-gamma and tumor necrosis factor upon stimulation with tumor targets.

Authors:  A S Chong; A Aleksijevic; P Scuderi; E M Hersh; W J Grimes
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

7.  Effects of tumour necrosis factor-alpha (TNF-alpha), IL-1 beta and monocytes on lymphokine-activated killer (LAK) induction from natural killer (NK) cells and T lymphocytes.

Authors:  K Yoneda; T Osaki; T Yamamoto; E Ueta
Journal:  Clin Exp Immunol       Date:  1993-08       Impact factor: 4.330

8.  Mouse tumors are heterogeneous in their susceptibility to syngeneic lymphokine-activated killer cells and delineate functional subsets in such effectors.

Authors:  M Sensi; L Grazioli; M Rodolfo; G Parmiani
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

9.  Lymphokine-activated killer cell function of peripheral blood mononuclear cells, spleen cells and regional lymph node cells in gastric cancer patients.

Authors:  N Karimine; S Arinaga; H Inoue; S Nanbara; H Ueo; T Akiyoshi
Journal:  Clin Exp Immunol       Date:  1994-06       Impact factor: 4.330

10.  Lymphokine-activated killer induction and its regulation by macrophages in malignant pleural effusions.

Authors:  H Yanagawa; S Sone; A Nii; K Fukuta; M Nakanishi; K Maeda; M Honda; T Ogura
Journal:  Jpn J Cancer Res       Date:  1989-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.